Mirae Asset Global Investments
IMCR icon

Mirae Asset Global Investments’s Immunocore IMCR Stock Holding History

Mirae Asset Global Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.2K Sell
1,989
-299
-13% -$8.85K ﹤0.01% 1326
2026
Q1 		$69K Buy
2,288
+168
+8% +$5.43K ﹤0.01% 1238
2025
Q4 		$73.6K Buy
2,120
+572
+37% +$20.2K ﹤0.01% 1314
2025
Q3 		$56.2K Buy
1,548
+13
+0.8% +$442 ﹤0.01% 1322
2025
Q2 		$48.2K Buy
1,535
+209
+16% +$6.49K ﹤0.01% 1265
2025
Q1 		$39.2K Buy
1,326
+7
+0.5% +$210 ﹤0.01% 1286
2024
Q4 		$38.5K Sell
1,319
-79
-6% -$2.5K ﹤0.01% 1308
2024
Q3 		$43.9K Buy
1,398
+285
+26% +$10.4K ﹤0.01% 1326
2024
Q2 		$37.6K Buy
+1,113
New +$56.8K ﹤0.01% 1297
2024
Q1 		– Sell
-16,152
Closed -$1.1M – 2540
2023
Q4 		$1.1M Buy
16,152
+3,623
+29% +$188K ﹤0.01% 1570
2023
Q3 		$650K Buy
+12,529
New +$741K ﹤0.01% 1757

Other funds holding IMCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Mirae Asset Global Investments's IMCR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Immunocore (IMCR) stake by 13% in Q2 2026, selling an estimated $8.85K and leaving 1,989 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

Mirae Asset Global Investments first reported a position in IMCR in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.1M in Q4 2023. 37 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Mirae Asset Global Investments held 1,989 shares of Immunocore worth $63.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 299 Immunocore shares in Q2 2026, an estimated $8.85K.
  • Immunocore made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1326 holding.
  • Mirae Asset Global Investments first reported a position in Immunocore in Q3 2023 and has held it in 11 quarters since.
  • Mirae Asset Global Investments's Immunocore position peaked at $1.1M in Q4 2023.
  • 37 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.